Report Detail
Global Inosine Pranobex Market Insights, Forecast to 2025
- RnM2723393 |
- 01 May, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
Inosine Pranobex is widely used to treat Immunomodulation, Antiviral and Other. The most proportion of Inosine Pranobex is to treat Antiviral, and the proportion is about 48.6% in 2017.
Europe region is the largest supplier of Inosine Pranobex, with a production market share nearly 57% in 2017. North America is the second largest supplier of Inosine Pranobex, enjoying revenue market share nearly 8.7% in 2017.
The global Inosine Pranobex market is valued at 180 million US$ in 2018 and will reach 220 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Inosine Pranobex market based on company, product type, end user and key regions.
This report studies the global market size of Inosine Pranobex in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Inosine Pranobex in these regions.
This research report categorizes the global Inosine Pranobex market by top players/brands, region, type and end user. This report also studies the global Inosine Pranobex market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Sigma -Tau
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
Market size by Product
Tablet
Syrup
Market size by End User
Immunomodulation
Antiviral
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Inosine Pranobex market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Inosine Pranobex market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Inosine Pranobex companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Inosine Pranobex submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Inosine Pranobex are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Inosine Pranobex market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Inosine Pranobex Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Inosine Pranobex Market Size Growth Rate by Product
- 1.4.2 Tablet
- 1.4.3 Syrup
- 1.5 Market by End User
- 1.5.1 Global Inosine Pranobex Market Size Growth Rate by End User
- 1.5.2 Immunomodulation
- 1.5.3 Antiviral
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Inosine Pranobex Market Size
- 2.1.1 Global Inosine Pranobex Revenue 2014-2025
- 2.1.2 Global Inosine Pranobex Sales 2014-2025
- 2.2 Inosine Pranobex Growth Rate by Regions
- 2.2.1 Global Inosine Pranobex Sales by Regions
- 2.2.2 Global Inosine Pranobex Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Inosine Pranobex Sales by Manufacturers
- 3.1.1 Inosine Pranobex Sales by Manufacturers
- 3.1.2 Inosine Pranobex Sales Market Share by Manufacturers
- 3.1.3 Global Inosine Pranobex Market Concentration Ratio (CR5 and HHI)
- 3.2 Inosine Pranobex Revenue by Manufacturers
- 3.2.1 Inosine Pranobex Revenue by Manufacturers (2014-2019)
- 3.2.2 Inosine Pranobex Revenue Share by Manufacturers (2014-2019)
- 3.3 Inosine Pranobex Price by Manufacturers
- 3.4 Inosine Pranobex Manufacturing Base Distribution, Product Types
- 3.4.1 Inosine Pranobex Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Inosine Pranobex Product Type
- 3.4.3 Date of International Manufacturers Enter into Inosine Pranobex Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Inosine Pranobex Sales by Product
- 4.2 Global Inosine Pranobex Revenue by Product
- 4.3 Inosine Pranobex Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Inosine Pranobex Breakdown Data by End User
6 North America
- 6.1 North America Inosine Pranobex by Countries
- 6.1.1 North America Inosine Pranobex Sales by Countries
- 6.1.2 North America Inosine Pranobex Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Inosine Pranobex by Product
- 6.3 North America Inosine Pranobex by End User
7 Europe
- 7.1 Europe Inosine Pranobex by Countries
- 7.1.1 Europe Inosine Pranobex Sales by Countries
- 7.1.2 Europe Inosine Pranobex Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Inosine Pranobex by Product
- 7.3 Europe Inosine Pranobex by End User
8 Asia Pacific
- 8.1 Asia Pacific Inosine Pranobex by Countries
- 8.1.1 Asia Pacific Inosine Pranobex Sales by Countries
- 8.1.2 Asia Pacific Inosine Pranobex Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Inosine Pranobex by Product
- 8.3 Asia Pacific Inosine Pranobex by End User
9 Central & South America
- 9.1 Central & South America Inosine Pranobex by Countries
- 9.1.1 Central & South America Inosine Pranobex Sales by Countries
- 9.1.2 Central & South America Inosine Pranobex Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Inosine Pranobex by Product
- 9.3 Central & South America Inosine Pranobex by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Inosine Pranobex by Countries
- 10.1.1 Middle East and Africa Inosine Pranobex Sales by Countries
- 10.1.2 Middle East and Africa Inosine Pranobex Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Inosine Pranobex by Product
- 10.3 Middle East and Africa Inosine Pranobex by End User
11 Company Profiles
- 11.1 Newport Pharmaceuticals
- 11.1.1 Newport Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Newport Pharmaceuticals Inosine Pranobex Products Offered
- 11.1.5 Newport Pharmaceuticals Recent Development
- 11.2 Gedeon Richter
- 11.2.1 Gedeon Richter Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Gedeon Richter Inosine Pranobex Products Offered
- 11.2.5 Gedeon Richter Recent Development
- 11.3 Mochida
- 11.3.1 Mochida Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Mochida Inosine Pranobex Products Offered
- 11.3.5 Mochida Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Inosine Pranobex Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 Andrómaco
- 11.5.1 Andrómaco Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Andrómaco Inosine Pranobex Products Offered
- 11.5.5 Andrómaco Recent Development
- 11.6 Yung Shin
- 11.6.1 Yung Shin Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Yung Shin Inosine Pranobex Products Offered
- 11.6.5 Yung Shin Recent Development
- 11.7 Sigma -Tau
- 11.7.1 Sigma -Tau Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sigma -Tau Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sigma -Tau Inosine Pranobex Products Offered
- 11.7.5 Sigma -Tau Recent Development
- 11.8 Polfarmex
- 11.8.1 Polfarmex Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Polfarmex Inosine Pranobex Products Offered
- 11.8.5 Polfarmex Recent Development
- 11.9 Sanfer
- 11.9.1 Sanfer Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sanfer Inosine Pranobex Products Offered
- 11.9.5 Sanfer Recent Development
- 11.10 Meprofarm
- 11.10.1 Meprofarm Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Meprofarm Inosine Pranobex Products Offered
- 11.10.5 Meprofarm Recent Development
- 11.11 Novell Pharmaceutical
- 11.12 Aflofarm
12 Future Forecast
- 12.1 Inosine Pranobex Market Forecast by Regions
- 12.1.1 Global Inosine Pranobex Sales Forecast by Regions 2019-2025
- 12.1.2 Global Inosine Pranobex Revenue Forecast by Regions 2019-2025
- 12.2 Inosine Pranobex Market Forecast by Product
- 12.2.1 Global Inosine Pranobex Sales Forecast by Product 2019-2025
- 12.2.2 Global Inosine Pranobex Revenue Forecast by Product 2019-2025
- 12.3 Inosine Pranobex Market Forecast by End User
- 12.4 North America Inosine Pranobex Forecast
- 12.5 Europe Inosine Pranobex Forecast
- 12.6 Asia Pacific Inosine Pranobex Forecast
- 12.7 Central & South America Inosine Pranobex Forecast
- 12.8 Middle East and Africa Inosine Pranobex Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Inosine Pranobex Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Inosine Pranobex . Industry analysis & Market Report on Inosine Pranobex is a syndicated market report, published as Global Inosine Pranobex Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Inosine Pranobex market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
